A long expected and encouraging statement made by NIDA’s (National Institue on Drug Abuse) director, Nora Volkow.
After 40 years of denying marijuana, Dr. Volkow announced that NIDA has a positive attitude towards CBD and considers it as a “safe drug”, although marijuana and all its constituents are still treated as a Schedule I harmful substance. CBD is abbreviated from Cannabidiol, one of the main and the two best studied components in cannabis (cannabinoids). The second best studied ingredient is THC (trans-Δ9-tetrahydrocannabinol). THC is a psychoactive cannabinoid and is often to blame for its high effect, considered to be adverse for patients and cause mythic addiction.
The signing of the Controlled Substances Act in 1970 had sealed and slowed down cannabis studies, but regardless the prohibition, researchers have presented countless medical and scientific evidences of the Endocannabinoid System (ES) in the human body and how CBD and other marijuana constituents collaborate with it. It is scientifically proved, that our body produces cannabinoids for itself, and if it fails to do so, marijuana natural components can help to perform required functions through CB1 and CB2 receptors of the ES.
NIDA has finally recognized CBD has different therapeutic values that may help to treat a list of diseases. Preclinical studies and clinical trials show CBD is non psychoactive, can treat psychiatric, neurodegenerative, sleep disorders, epilepsy, possesses anti-cancer properties, mitigates harmful effects of chemo- and radiotherapies treatment, the list is vast. On the one hand, the third of the states allow medical use of weed and prescribe it to qualified patients, yet, on the other hand, it is illicit on the federal level.
Hopefully, this statement can bring cannabis industry to a new level and provide more opportunities for researches. NIDA also admits there are barriers and obstacles on the way of CBD and the cannabis science in general, and promises to do their best to make it smoother.
Also, despite the rumors that the U.S. new government may roll back medical and recreational marijuana initiatives, more and more people expect the number of the states where cannabis is legal to grow.